UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 715

Sortiert nach

Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1544-1552

1997

Volltextzugriff (PDF)

Anthracycline associated cardiotoxicity in survivors of childhood cancer

Heart (British Cardiac Society), 2008-04, Vol.94 (4), p.525-533

2008

Volltextzugriff (PDF)

Epidemiology of anthracycline cardiotoxicity in children and adults

Seminars in oncology, 1998-08, Vol.25 (4 Suppl 10), p.72

1998

Volltextzugriff (PDF)

Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia

Journal of clinical oncology, 1998-02, Vol.16 (2), p.545-550

1998

Volltextzugriff (PDF)

Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury

Circulation (New York, N.Y.), 1997-10, Vol.96 (8), p.2641-2648

1997

Volltextzugriff (PDF)

Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia

The pharmacogenomics journal, 2016-11, Vol.16 (6), p.530-535

2016

Volltextzugriff (PDF)

Correlation Between Serum Levels of Cardiac Troponin-T and the Severity of the Chronic Cardiomyopathy Induced by Doxorubicin

Journal of clinical oncology, 1999-07, Vol.17 (7), p.2237-2243

1999

Volltextzugriff (PDF)

Anthracycline-induced cardiotoxicity in children and young adults

Critical reviews in oncology/hematology, 1998, Vol.27 (1), p.53-68

1998

Volltextzugriff (PDF)

Dilated Cardiomyopathy in HIV-Infected Patients

The New England journal of medicine, 1998-10, Vol.339 (16), p.1153-1155

Lipshultz, Steven E

1998

Volltextzugriff (PDF)

Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood

The New England journal of medicine, 1991-03, Vol.324 (12), p.808-815

1991

Volltextzugriff (PDF)

Design and implementation of the North American Pediatric Cardiomyopathy Registry

The American heart journal, 2000-02, Vol.139 (2), p.s86-s95

2000

Volltextzugriff (PDF)

Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity

Cancer research (Chicago, Ill.), 1998-01, Vol.58 (2), p.195-197

1998

Volltextzugriff (PDF)

Monitoring for anthracycline cardiotoxicity

Pediatrics (Evanston), 1994-03, Vol.93 (3), p.433

1994

Volltextzugriff (PDF)

Clinical approach to genetic cardiomyopathy in children

Circulation (New York, N.Y.), 1996-10, Vol.94 (8), p.2021-2038

1996

Volltextzugriff (PDF)

Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia

The pharmacogenomics journal, 2017-01, Vol.17 (1), p.107-107

2017

Volltextzugriff (PDF)

The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV disease

Journal of the American College of Cardiology, 1999-09, Vol.34 (3), p.857-865

1999

Volltextzugriff (PDF)

Maternal Calcium Intake During Pregnancy and Blood Pressure in the Offspring at Age 3 Years: A Follow-up Analysis of the Project Viva Cohort

American journal of epidemiology, 2008-12, Vol.168 (12), p.1374-1380

2008

Volltextzugriff (PDF)

Non-invasive assessment of rejection in pediatric transplant patients: serologic and echocardiographic prediction of biopsy-proven myocardial rejection

The Journal of heart and lung transplantation, 2000-08, Vol.19 (8), p.756-764

2000

Volltextzugriff (PDF)

Cardiac complications in children with human immunodeficiency virus infection. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group, National Heart, Lung, and Blood Institute

Pediatrics (Evanston), 1999-08, Vol.104 (2), p.e14

1999

Volltextzugriff (PDF)

Immunoglobulins and left ventricular structure and function in pediatric HIV infection

Circulation (New York, N.Y.), 1995-10, Vol.92 (8), p.2220-2225

1995

Volltextzugriff (PDF)

Cardiovascular abnormalities in long-term survivors of childhood malignancy

Journal of clinical oncology, 1993-07, Vol.11 (7), p.1199-1203

1993

Volltextzugriff (PDF)

Doxorubicin Administration by Continuous Infusion Is Not Cardioprotective: The Dana-Farber 91-01 Acute Lymphoblastic Leukemia Protocol

Journal of clinical oncology, 2002-03, Vol.20 (6), p.1677-1682

Lipshultz, S. E.

2002

Volltextzugriff (PDF)

Doxorubicin-Induced Cardiomyopathy

The New England journal of medicine, 1999-02, Vol.340 (8), p.653-655

1999

Volltextzugriff (PDF)

Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer

The New England journal of medicine, 1995-06, Vol.332 (26), p.1738-1744

1995

Volltextzugriff (PDF)

The imperative to prevent and treat childhood obesity: why the world cannot afford to wait

Clinical obesity, 2013-12, Vol.3 (6), p.163-171

2013

Volltextzugriff (PDF)

1 – 25 von 715

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(654)
Mit Volltextzugriff
(611)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(427)
Life Sciences & Biomedicine
(423)
Humans
(359)
Male
(233)
Child
(181)
Female
(180)
Pediatrics
(176)
Biological And Medical Sciences
(174)
Medical Sciences
(172)
Cardiac & Cardiovascular Systems
(153)
Cardiovascular System & Cardiology
(153)
Adolescent
(119)
Child, Preschool
(115)
Risk Factors
(104)
Adult
(100)
Infant
(90)
Cardiomyopathy
(79)
Cardiovascular
(64)
Oncology
(64)
Heart
(57)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience

Anthracycline associated cardiotoxicity in survivors of childhood cancer

Epidemiology of anthracycline cardiotoxicity in children and adults

Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia

Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury

Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia

Correlation Between Serum Levels of Cardiac Troponin-T and the Severity of the Chronic Cardiomyopathy Induced by Doxorubicin

Anthracycline-induced cardiotoxicity in children and young adults

Dilated Cardiomyopathy in HIV-Infected Patients

Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood

Design and implementation of the North American Pediatric Cardiomyopathy Registry

Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity

Monitoring for anthracycline cardiotoxicity

Clinical approach to genetic cardiomyopathy in children

Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia

The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV disease

Maternal Calcium Intake During Pregnancy and Blood Pressure in the Offspring at Age 3 Years: A Follow-up Analysis of the Project Viva Cohort

Non-invasive assessment of rejection in pediatric transplant patients: serologic and echocardiographic prediction of biopsy-proven myocardial rejection

Cardiac complications in children with human immunodeficiency virus infection. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group, National Heart, Lung, and Blood Institute

Immunoglobulins and left ventricular structure and function in pediatric HIV infection

Cardiovascular abnormalities in long-term survivors of childhood malignancy

Doxorubicin Administration by Continuous Infusion Is Not Cardioprotective: The Dana-Farber 91-01 Acute Lymphoblastic Leukemia Protocol

Doxorubicin-Induced Cardiomyopathy

Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer

The imperative to prevent and treat childhood obesity: why the world cannot afford to wait

Suchergebnisse filtern